This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEA601E0_M.jpg
The company was notified that it had fallen short of the NYSE’s continued listing standards, specifically Sections 1003(a)(i), (ii), and (iii) as of November 30, 2023. In response to this warning, AAMC is preparing to appeal within the stipulated seven-day period.
AAMC’s financial health is under scrutiny due to several risk factors outlined in recent SEC filings. Among these are employee costs and ongoing litigation issues related to its Series A Convertible Preferred Stock. The outcome of the appeal and subsequent ruling by the Listings Qualifications Panel will be critical for the company’s continued presence on the NYSE.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
